Examination of the effect of continuous intake of test food for 8 weeks for healthy adults on immune functio
- Conditions
- Healthy subjects
- Registration Number
- JPRN-UMIN000038622
- Lead Sponsor
- HUMA R&D CORP
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Not provided
1.Subject who is taking medication or under medical treatment because of some serious illness. 2.Subject who is under exercise therapy or dietetic therapy. 3.Subject who has an allergy for test food. 4.Subject who has or had a history of either medicine or alcohol dependence syndrome. 5.Subject who has or had a history of mental illness (depression) or sleep disturbance. 6.Subject who is on a night-shift worker. 7.Subject whose lifestyle is extremely irregular. 8.Subject who has an unbalanced diet. 9.Subject who is disease or history such severe diseases such as brain disease, malignant tumor, immune disease, diabetes, liver disease (hepatitis), kidney disease, heart disease, thyroid disease, adrenal disease, other metabolic diseases person. 10.Subject who uses drugs that may affect immune function (antibiotics, immunosuppressants, anti-inflammatory drugs, antirheumatic drugs, antihistamines, antiallergic drugs, lactic acid bacteria preparations, etc.) 11.Subject who uses health foods that affect immune function (such as yogurt products with functionality (immunity activation)), supplements, and pharmaceuticals 12.Subject who has participated in other clinical studies within the past 3 months from the day of the consent acquisition or who is planning to participate in other clinical studies during the current study. 13.Subject who performs intense exercises such as jogging, marathon and soccer 14.Subject who has blood drawn 200mL within the past 1 months or 400mL within the past 3 months from the day of the consent acquisition. 15.Subject who is currently pregnant or lactating, or planning to get pregnant. 16.Subject who can't keep the daily records. 17.Subject who is judged to be inappropriate as test subject from clinical laboratory test values and measurement values at the time of SCR. 18.Subject who is considered as an inappropriate candidate by the doctor in charge.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Wisconsin upper respiratory symptom survey-21 (WURSS-21)
- Secondary Outcome Measures
Name Time Method POMS2 shortened version, peripheral blood image, NK cell activity, immunity evaluation, each item scores, flow cytometry analysis data, analysis data, secretory IgA